Analyst consensus rating
Clover Health Investments Analyst Rating: none
Direct answer
Clover Health Investments's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.38.
Forecast evidence checked September 27, 2026.
Get free Clover Health Investments email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.49
- Average price target
- $5.38
- High price target
- $6.00
- Low price target
- $5.00
- Low target gap
- +11.4%
- Target upside
- +19.7%
- High target gap
- +33.6%
- Target range width
- 22.3%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 27, 2026
- Valid through
- October 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Clover Health Investments?
Clover Health Investments has a verified none consensus. The same dataset has an average price target of $5.38.
How far are Clover Health Investments's low and high targets from the recorded price?
The low target implies +11.4%, while the high target implies +33.6%.
How many analysts are included in Clover Health Investments's consensus?
The verified consensus includes 4 analysts.
How is Clover Health Investments's target upside or downside calculated?
The average target of $5.38 is divided by the recorded price of $4.49, then one is subtracted to produce +19.7%. This does not guarantee a future return.
When was Clover Health Investments's analyst forecast verified?
The data was verified on 2026-09-27. The dataset is valid through 2026-10-04.